Jiejun Wang
Impact in
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
Papers in
-
- Advanced Memory and Neural Computing 10
- Co-authors
- Shukui Qin (3 shared papers)Zhongzhen Guan (2 shared papers)Jianming Xu (2 shared papers)Chao-Jung Tsao (1 shared paper)Houjie Liang (1 shared paper)Jiwei Liu (1 shared paper)Yoon‐Koo Kang (1 shared paper)D. Voliotis (1 shared paper)
- Journals
- Frontiers in Neurology (8 papers)Medical Oncology (4 papers)BMC Cancer (4 papers)Oncotarget (3 papers)CORROSION (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Jiejun Wang
119 papers receiving 6.5k citations
Jiejun Wang's Hit Papers
Peers
Comparison fields: 5 of 142
- Hepatology 3.1k
- Cancer Research 1.1k
- Pathology and Forensic Medicine 840
- Oncology 945
- Epidemiology 916
Countries citing papers authored by Jiejun Wang
This map shows the geographic impact of Jiejun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiejun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiejun Wang more than expected).
Fields of papers citing papers by Jiejun Wang
This network shows the impact of papers produced by Jiejun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiejun Wang. The network helps show where Jiejun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiejun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2008 | 4754 |
| 2 | 2009 | 138 | |
| 3 | 2013 | 118 | |
| 4 | 2010 | 76 | |
| 5 | 2022 | 65 | |
| 6 | 2012 | 63 | |
| 7 | 2015 | 63 | |
| 8 | 2008 | 60 | |
| 9 | 2012 | 56 | |
| 10 | 2018 | 54 | |
| 11 | 2015 | 51 | |
| 12 | 2014 | 47 | |
| 13 | 2014 | 45 | |
| 14 | 2010 | 44 | |
| 15 | 2013 | 42 | |
| 16 | 2007 | 40 | |
| 17 | 2014 | 37 | |
| 18 | 2015 | 33 | |
| 19 | 2013 | 31 | |
| 20 | 2011 | 30 |
About Jiejun Wang
Jiejun Wang is a scholar working on Electrical and Electronic Engineering, Molecular Biology, Mechanical Engineering, Neurology and Pulmonary and Respiratory Medicine, having authored 128 papers that have together received 6.6k indexed citations. Recurring topics across this work include Intracranial Aneurysms: Treatment and Complications (11 papers), Advanced Memory and Neural Computing (10 papers), Structural Load-Bearing Analysis (8 papers), Wood Treatment and Properties (8 papers), Transition Metal Oxide Nanomaterials (6 papers), Heat Transfer and Boiling Studies (6 papers), Structural Engineering and Vibration Analysis (5 papers) and Heat Transfer and Optimization (5 papers). The work is most often cited by research in Hepatology (3.1k citations), Cancer Research (1.1k citations), Pathology and Forensic Medicine (840 citations), Oncology (945 citations) and Epidemiology (916 citations). Jiejun Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shukui Qin, Zhongzhen Guan, Jianming Xu, Chao-Jung Tsao, Houjie Liang, Jiwei Liu, Yoon‐Koo Kang, D. Voliotis, K. Burock and Ann‐Lii Cheng. Their work appears in journals such as Frontiers in Neurology, Medical Oncology, BMC Cancer, Oncotarget and CORROSION.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.